Overview
AMIX market data
Price History
AMIX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.32 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.37 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.44 – $32.55 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $9M · P/B 0.76.
Company News
Autonomix Medical Q1 EPS $(5.02) Beats $(6.93) EstimateBenzinga · Aug 13, 2026, 10:30 AM
Autonomix Medical shares are trading lower. The company announced the completion of its GLP pre-clinical study.Benzinga · Aug 12, 2026, 4:38 PM
Autonomix Medical Announces Completion Of GLP Pre-Clinical Study In Porcine Models; Says Final Histopathology, Laboratory Findings Support Safety And Performance Objectives Ahead Of FDA SubmissionBenzinga · Aug 12, 2026, 12:17 PM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Aug 7, 2026, 5:05 PM
Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 5, 2026, 8:57 AM
SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars TodayBenzinga · Aug 5, 2026, 1:45 AM
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech PatentBenzinga · Aug 4, 2026, 7:27 PM
Autonomix Medical shares are trading higher after the company announced the issuance of U.S. Patent No. 12,433,670, titled "Systems and Methods for Treating Cancer and/or Augmenting Organ Function."Benzinga · Aug 4, 2026, 2:18 PM
Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 EarningsBenzinga · Aug 4, 2026, 1:41 PM
Autonomix Medical Shares Halted On Circuit Breaker To The Upside, Stock Now Up 72.60%Benzinga · Aug 4, 2026, 1:32 PM